Gaurav Agarwal, Co-Chair of the Medical Devices Committee at PHDCCI, highlights the balanced approach of India’s Central Drugs Standard Control Organisation (CDSCO) in eliminating clinical trial waivers for in-vitro diagnostics (IVDs). This decision ensures both patient safety and fosters innovation within the healthcare sector. India's
